Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| (11 intermediate revisions by the same user not shown) | |||
| Line 19: | Line 19: | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
| − | + | *[[Media:06 10 2022 QIBA CEUS BC Call Summary-FINAL.pdf|June 10, 2022]] | |
| − | *[[Media: | + | *[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]] |
| − | *[[Media: | + | *[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]] |
| − | *[[Media:03 | + | *[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]] |
| − | *[[Media:02 | + | *[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]] |
Revision as of 18:37, 26 May 2022
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: